eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

Would you have Pulmonary embolism when you have Kidney stones?

Summary: Pulmonary embolism is reported only by a few people with Kidney stones.

We study 4 people who have Pulmonary embolism and Kidney stones from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

You are not alone: join a support group for people who have Kidney stones and Pulmonary embolism >>>


Kidney stones

Kidney stones can be treated by Allopurinol, Potassium Citrate, Flomax, Urocit-k, Hydrochlorothiazide, Tamsulosin. (latest reports from 14,363 Kidney Stones patients)

Pulmonary embolism

Pulmonary embolism (blockage of the main artery of the lung) has been reported by people with birth control, pain, premenstrual syndrome, acne, high blood pressure. (latest reports from 61,170 Pulmonary embolism patients)

On Mar, 30, 2015: 4 people who have kidney stones and Pulmonary Embolism are studied.

Trend of Pulmonary embolism in kidney stones reports

Gender of people who have kidney stones and experienced Pulmonary embolism * :

Pulmonary embolism100.00%0.00%

Age of people who have kidney stones and experienced Pulmonary embolism * :

Pulmonary embolism0.00%0.00%0.00%25.00%0.00%0.00%75.00%0.00%

Severity of the symptom * :


Top co-existing conditions for these people * :

  1. Nephrolithiasis (4 people, 100.00%)
  2. Renal disorder (3 people, 75.00%)
  3. Abdominal discomfort (3 people, 75.00%)
  4. Prophylaxis (3 people, 75.00%)
  5. Crohn's disease (3 people, 75.00%)

Most common drugs used by these people * :

  1. Potassium citrate (3 people, 75.00%)
  2. Lisinopril (3 people, 75.00%)
  3. Humira (3 people, 75.00%)
  4. Ranitidine (3 people, 75.00%)
  5. Azathioprine (3 people, 75.00%)
  6. Enoxaparin sodium (3 people, 75.00%)
  7. Mesalamine (3 people, 75.00%)
  8. Levaquin (1 people, 25.00%)
  9. Yasmin (1 people, 25.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Get connected: join our support group of kidney stones and pulmonary embolism on

Do you have Kidney Stones and Pulmonary Embolism?




You are not alone! Join a support group on :
- support group for people who have Pulmonary Embolism and Kidney stones
- support group for people who have Kidney stones
- support group for people who have Pulmonary Embolism

Could your drug cause:

Other conditions that could cause:

Recent related drug studies (Check your drugs):

Recent Kidney Stones related drug comparison:

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.


About - Terms of service - Privacy policy - Press - Testimonials - Contact us -

© 2015 All rights reserved. Use of this site constitutes acceptance of's terms of service and privacy policy.